Vascular Disorder Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Vascular Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

Diabetic RetinopathyHypertension,EssentialRetinal Vein Occlusion+1 more
Johns Hopkins University1,050 enrolled1 locationNCT04505618
Recruiting

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Classic Hodgkin LymphomaCardiovascular DisorderClonal Hematopoiesis
Children's Oncology Group190 enrolled29 locationsNCT05705531
Recruiting
Not Applicable

Robot-Assisted Neurovascular Intervention

MeningiomaStrokeNeurovascular Disorder
Navigantis Inc.10 enrolled1 locationNCT06752096
Recruiting

Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

Brain DiseasesCentral Nervous System DiseasesAtrial Fibrillation+11 more
Insel Gruppe AG, University Hospital Bern500 enrolled1 locationNCT06954610
Recruiting
Phase 1

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NeoplasmLymphoproliferative DisordersNeoplasms by Histologic Type+11 more
Kelonia Therapeutics, Inc.40 enrolled3 locationsNCT07075185
Recruiting

Environmental Pollutants and Neurological Disorders

Brain TumoursCerebrovascular DisordersAlzheimer Dementia
Beijing Tiantan Hospital500 enrolled1 locationNCT07140601
Recruiting
Phase 2

Repurposing Valsartan May Protect Against Pulmonary Hypertension

Pulmonary Arterial HypertensionRight Ventricular DysfunctionRight Heart Failure+1 more
University of Washington60 enrolled1 locationNCT06053580
Recruiting

International Intracranial Dissection Study

StrokeCerebrovascular DisordersVascular: Intracranial+1 more
Insel Gruppe AG, University Hospital Bern500 enrolled3 locationsNCT02756091
Recruiting

Cerebrovascular Disease: Quality of Life (CODE: QoL)

Quality of LifeStressCaregiver Burden+7 more
University of Zurich680 enrolled1 locationNCT06443268
Recruiting

Advances in Telephone-based Cognitive Screening Procedures

Amyotrophic Lateral SclerosisCerebrovascular DisordersAlzheimer s Disease+2 more
Istituto Auxologico Italiano280 enrolled1 locationNCT06337578
Recruiting

Hypertension Explored in Long-term Postpartum Follow-up in Later Life

Cardiovascular DiseasesHypertensionCerebrovascular Disorders+1 more
University of Oxford200 enrolled1 locationNCT06187012
Recruiting

The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

Cognitive ImpairmentStrokeCerebrovascular Disorders+3 more
Imperial College London700 enrolled1 locationNCT05885295
Recruiting
Phase 1Phase 2

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Sexual DysfunctionAutoimmune DiseasesNeurologic Disorders+8 more
Thomas Advanced Medical LLC5,000 enrolled1 locationNCT04684602